Last updated on July 2020

Study of Safety Tolerability and PK PD of HPG1860 in Healthy Subjects

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy
  • Age: Between 18 - 55 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Healthy subjects aged 18-55 years old (inclusive), male or female
  2. Females must be of non-childbearing potential
  3. Have a body mass index (BMI) between 18.0 and 32.0 kg/m2 (inclusive) and weigh at least 50 kg at time of Screening

Exclusion Criteria:

  1. Clinically significant history of gastrointestinal, cardiovascular, musculoskeletal, endocrine, hematologic, psychiatric, renal, hepatic, bronchopulmonary, neurologic, immunologic, lipid metabolism disorders, or drug hypersensitivity as determined by the Investigator
  2. Taken an investigational drug within 3 months or 5 half-live, whichever is longer from the Screening date
  3. Any liver function panel analyte (LFT) value > upper limits of normal reference range
  4. Positive blood screen for human immunodeficiency virus (HIV), hepatitis B core (IgG and IgM) and surface antigen (HBsAg), Hepatitis A antibody (IgM), hepatitis C antibody (IgG), or hepatitis E (IgG and IgM) at Screening
  5. Any condition or finding that in the opinion of the Principal Investigator or designee would put the subject or study conduct at risk if the subject were to participate in the study

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.